Trial Profile
A study of adalimumab for the treatment of hidradenitis suppurativa Hurley III stage in patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2017
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Hidradenitis suppurativa
- Focus Therapeutic Use
- 08 Jun 2017 New trial record